These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 21906124)

  • 41. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris.
    Mahoney MG; Wang Z; Rothenberger K; Koch PJ; Amagai M; Stanley JR
    J Clin Invest; 1999 Feb; 103(4):461-8. PubMed ID: 10021453
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bullous dermatosis associated with IgG antibodies specific for desmocollins.
    Endo Y; Tsujioka K; Tanioka M; Minegaki Y; Ohyama B; Hashimoto T; Miyachi Y; Utani A
    Eur J Dermatol; 2010; 20(5):620-5. PubMed ID: 20610368
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The molecular logic of pemphigus and impetigo: the desmoglein story.
    Amagai M
    Vet Dermatol; 2009 Oct; 20(5-6):308-12. PubMed ID: 20178466
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-Desmocollin Autoantibodies in Autoimmune Blistering Diseases.
    Bosch-Amate X; Iranzo P; Ivars M; Mascaró Galy JM; España A
    Front Immunol; 2021; 12():740820. PubMed ID: 34567003
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Apoptosis is not required for acantholysis in pemphigus vulgaris.
    Schmidt E; Gutberlet J; Siegmund D; Berg D; Wajant H; Waschke J
    Am J Physiol Cell Physiol; 2009 Jan; 296(1):C162-72. PubMed ID: 18987254
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cutaneous type pemphigus vulgaris: a rare clinical phenotype of pemphigus.
    Yoshida K; Takae Y; Saito H; Oka H; Tanikawa A; Amagai M; Nishikawa T
    J Am Acad Dermatol; 2005 May; 52(5):839-45. PubMed ID: 15858475
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of intramolecular epitope spreading in pemphigus vulgaris.
    Salato VK; Hacker-Foegen MK; Lazarova Z; Fairley JA; Lin MS
    Clin Immunol; 2005 Jul; 116(1):54-64. PubMed ID: 15925832
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Significance of autoimmunity to non-desmoglein targets in pemphigus.
    Kurzen H; Brenner S
    Autoimmunity; 2006 Nov; 39(7):549-56. PubMed ID: 17101498
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Apoptotic pathways in the pathogenesis of pemphigus: targets for new therapies.
    Lotti R; Marconi A; Pincelli C
    Curr Pharm Biotechnol; 2012 Aug; 13(10):1877-81. PubMed ID: 22250711
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pemphigus vulgaris antibodies target the mitochondrial nicotinic acetylcholine receptors that protect keratinocytes from apoptolysis.
    Chernyavsky A; Chen Y; Wang PH; Grando SA
    Int Immunopharmacol; 2015 Nov; 29(1):76-80. PubMed ID: 25998908
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antibodies to desmogleins 1 and 3, but not to BP180, induce blisters in human skin grafted onto SCID mice.
    Zillikens D; Schmidt E; Reimer S; Chimanovitch I; Hardt-Weinelt K; Rose C; Bröcker EB; Kock M; Boehncke WH
    J Pathol; 2001 Jan; 193(1):117-24. PubMed ID: 11169524
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins.
    Ishii K; Amagai M; Hall RP; Hashimoto T; Takayanagi A; Gamou S; Shimizu N; Nishikawa T
    J Immunol; 1997 Aug; 159(4):2010-7. PubMed ID: 9257868
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cutaneous pemphigus vulgaris with skin features similar to the classic mucocutaneous type: a case report and review of the literature.
    Shinkuma S; Nishie W; Shibaki A; Sawamura D; Ito K; Tsuji-Abe Y; Natsuga K; Chan PT; Amagai M; Shimizu H
    Clin Exp Dermatol; 2008 Nov; 33(6):724-8. PubMed ID: 18627395
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antidesmocollin-1 antibody-positive, antidesmoglein antibody-negative pemphigus herpetiformis.
    Tateishi C; Tsuruta D; Nakanishi T; Uehara S; Kobayashi H; Ishii M; Hashimoto T
    J Am Acad Dermatol; 2010 Jul; 63(1):e8-10. PubMed ID: 20542173
    [No Abstract]   [Full Text] [Related]  

  • 55. Immune modulation in pemphigus vulgaris: role of CD28 and IL-10.
    Toto P; Feliciani C; Amerio P; Suzuki H; Wang B; Shivji GM; Woodley D; Sauder DN
    J Immunol; 2000 Jan; 164(1):522-9. PubMed ID: 10605050
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mucocutaneous pemphigus vulgaris carrying high-titre antidesmoglein 1 antibodies with skin lesions resembling pemphigus erythematosus.
    Cirillo N; Santoro R; Lanza M; Annese P; Gombos F; Lanza A
    Clin Exp Dermatol; 2008 Jan; 33(1):32-5. PubMed ID: 17983457
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mechanisms Causing Loss of Keratinocyte Cohesion in Pemphigus.
    Spindler V; Eming R; Schmidt E; Amagai M; Grando S; Jonkman MF; Kowalczyk AP; Müller EJ; Payne AS; Pincelli C; Sinha AA; Sprecher E; Zillikens D; Hertl M; Waschke J
    J Invest Dermatol; 2018 Jan; 138(1):32-37. PubMed ID: 29037765
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Desmoglein ELISA in the diagnosis of pemphigus and its correlation with the severity of pemphigus vulgaris.
    Mortazavi H; Shahdi M; Amirzargar AA; Naraghi ZS; Valikhani M; Daneshpazhooh M; Vasheghani-Farahani A; Sedaghat M; Chams-Davatchi C
    Iran J Allergy Asthma Immunol; 2009 Mar; 8(1):53-6. PubMed ID: 19279360
    [TBL] [Abstract][Full Text] [Related]  

  • 59. From pemphix to desmogleins.
    Buzina DŠ; Marinović B
    Clin Dermatol; 2011; 29(4):355-9. PubMed ID: 21679863
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of a Novel Non-desmoglein Autoantigen in Pemphigus Vulgaris.
    Di Lullo G; Calabresi V; Mariotti F; Zambruno G; Lanzavecchia A; Di Zenzo G
    Front Immunol; 2019; 10():1391. PubMed ID: 31275324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.